Cargando…
The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects
BACKGROUND: The polymorphism Pro12Ala in peroxisome proliferator-activated receptorγ2 gene (PPARγ2) has been reported to be associated with diabetic nephropathy (DN) in some studies, though the results remain inconclusive. To explore this relationship between PPARγ2 Pro12Ala polymorphism and the su...
Autores principales: | Wang, Lei, Teng, Zan, Cai, Shuang, Wang, Difei, Zhao, Xin, Yu, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751054/ https://www.ncbi.nlm.nih.gov/pubmed/23856170 http://dx.doi.org/10.1186/1746-1596-8-118 |
Ejemplares similares
-
The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes
por: Lapice, Emanuela, et al.
Publicado: (2015) -
PPARγ2(Pro12Ala) Polymorphism and Human Health
por: He, Weimin
Publicado: (2009) -
PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes
por: Vales-Villamarín, Claudia, et al.
Publicado: (2021) -
Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?
por: Pereira, A. C., et al.
Publicado: (2013) -
Homozygosity for the Ala Allele of the PPARγ2 Pro12Ala Polymorphism Is Associated with Reduced Risk of Coronary Artery Disease
por: Galgani, Andrea, et al.
Publicado: (2010)